ARTICLES BY KATIE ANDERSON
-
Innovation, Growth (and Happiness) Projected for Pharma11/10/2025
Not only is investment increasing in pharma, but innovation is propelling growth in multiple drug segments, and the people supporting this growth and innovation remain happy.
-
Lab Oversupply Is Pushing Leasing, Rent and Relocation Down7/1/2025
The landscape of the U.S. pharmaceutical lab market is changing, according to JLL’s U.S. Life Sciences Property Report. In addition to the effort to bring pharma manufacturing back to the U.S. ahead of looming tariffs, an oversupply of space and lower tenant demand in large biopharma markets is dropping leasing rates, rent costs and lease duration, among other changes.